Issue |
Title |
File |
Vol 7, No 3 (2010) |
Kognitivnye narusheniya u bol'nykh s arterial'noy gipertoniey: novye dannye o vozmozhnosti ikh uluchsheniya na fone lecheniya eprosartanom |
|
Ostroumova O.D., Srednyakov A.V., Dudaev V.A., Stepura O.B.
|
Vol 8, No 2 (2011) |
Kombinatsiya amlodipinai atorvastatina - udachnyy duetv lechenii bol'nykh s metabolicheskimsindromom |
|
Blinova N.V., Chazova I.E.
|
Vol 7, No 4 (2010) |
Kombinatsiya antagonista retseptorov k angiotenzinu II s diuretikom: effektivnost', bezopasnost', pokazaniya k naznacheniyu. |
|
Ostroumova O.D., Srednyakov A.V., Smolyarchuk E.A.
|
Vol 7, No 3 (2010) |
Kombinatsiya ingibitora angiotenzinprevrashchayushchego fermenta i diuretika: optimizatsiya effektivnosti i bezopasnosti |
|
Ostroumova O.D., Stepura O.B., Bondarets O.V., Guseva T.F.
|
Vol 5, No 3 (2008) |
Kombinirovannaya terapiya - osnova lecheniya patsientov s arterial'noy gipertenziey |
|
Ratova L.G., Chazova I.E.
|
Vol 1, No 1 (2004) |
Kombinirovannaya terapiya arterial'noy gipertenzii |
|
Chazova I.E., Ratova L.G.
|
Vol 1, No 2 (2004) |
Kombinirovannaya terapiya arterial'noy gipertenzii s pozitsiy profilaktiki serdechno-sosudistykh oslozhneniy i patogeneza |
|
Boytsov S.A.
|
Vol 4, No 1 (2007) |
Kombinirovannaya terapiya arterial'noy gipertenzii: novaya nefiksirovannaya kombinatsiya |
|
Nebieridze D.V.
|
Vol 3, No 2 (2006) |
Kombinirovannaya terapiya ingibitorom angiotenzinprevrashchayushchego fermenta i diuretikom |
|
Chazova I.E., Martynyuk T.V.
|
Vol 7, No 2 (2010) |
Kombinirovannaya terapiya u patsientov s arterial'noy gipertoniey |
|
Chazova I.E., Ratova L.G.
|
Vol 3, No 1 (2006) |
Kompleksnaya otsenka elasticheskikh svoystv i reaktivnosti intrakranial'nykh i perifericheskikh arteriy u patsientov s gipertonicheskoy bolezn'yu |
|
Lebedev P.A., Maksimova L.N.
|
Vol 2, No 2 (2005) |
Korotkiy put' k zavetnoy tseli – ko-renitek dlya patsienta s AG |
|
Chazova I.E., Ratova L.G.
|
Vol 3, No 2 (2006) |
Korrektsiya disfunktsii endoteliya pri arterial'noy gipertonii: fokus na beta -blokatory |
|
Ostroumova O.D., Dubinskaya R.E., Zhukova O.V.
|
Vol 10, No 3 (2013) |
Korrektsiya dislipidemiy pri soputstvuyushchey arterial'noy gipertonii s pozitsiy obnovlennoy paradigmy serdechno-sosudistogo riska |
|
Gurevich V.S.
|
Vol 5, No 3 (2008) |
Korrektsiya narusheniy lipidnogo obmena u bol'nykh sakharnym diabetom tipa 2 |
|
Kozlov S.G., Lyakishev A.A.
|
Vol 4, No 2 (2007) |
Lechenie arterial'noy gipertenzii u pozhilykh bol'nykh |
|
Repin A.N., Sergienko T.N., Karpov R.S.
|
Vol 5, No 1 (2008) |
Lechenie arterial'noy gipertonii u bol'nykh s metabolicheskim sindromom |
|
Chazova I.E., Ratova L.G.
|
Vol 5, No 4 (2008) |
Lechenie arterial'noy gipertonii: sravnenie klinicheskoyi ekonomicheskoy effektivnosti original'nykh i genericheskikh preparatov |
|
Ostroumova O.D., Bondarets O.V., Shorikova E.G.
|
Vol 4, No 2 (2007) |
Lechenie dislipidemii kak vazhnyy faktor profilaktiki ateroskleroza i ego oslozhneniy |
|
Kukharchuk V.V.
|
Vol 3, No 1 (2006) |
Lechenie patsienta s arterial'noy gipertenziey i gipertrofiey levogo zheludochka |
|
Chazova I.E., Ratova L.G., Ataullakhanova D.M.
|
Vol 10, No 1 (2013) |
Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus |
|
Barsukov A.V., Glukhovskoy D.V., Talantseva M.S., Bagaeva Z.V., Pronina E.V., Zobnina M.P., Sveklina T.S., Korovin A.E.
|
Vol 10, No 2 (2013) |
Legochnaya arterial'naya gipertenziya: na puti ot ratsional'noy diagnostiki k vyboru effektivnoy lekarstvennoy terapii |
|
Chazova I.E., Martynyuk T.V.
|
Vol 1, No 1 (2004) |
Legochnaya gipertenziya pri khronicheskoy obstruktivnoy bolezni legkikh |
|
Avdeev S.N.
|
Vol 10, No 4 (2013) |
Lercanidipine as a calcium antagonist of the third generation: a review of effectiveness in the hypertension treatment |
|
Zadionchenko V.S., Shekhyan G.G., Yalymov A.A., Varentsov S.I.
|
Vol 9, No 2 (2012) |
Lerkanidipin - blokator kal'tsievykh kanalov III pokoleniya |
|
Kirichenko A.A.
|
Vol 7, No 1 (2010) |
Lerkanidipin - novyy antagonist kal'tsiya III pokoleniya dlya lecheniya arterial'noy gipertenzii (referat) |
|
Gasser R., Köppel H., Klein W.
|
Vol 4, No 1 (2007) |
Lerkanidipin – novyy blokator kal'tsievykh kanalov: effektivnost' primeneniya u bol'nykh arterial'noy gipertoniey |
|
Chikhladze N.M., Chazova I.E.
|
Vol 7, No 4 (2010) |
Letnyaya shkola po arterial'noy gipertonii 2010 g. v Khorvatii |
|
Makhiyanova E.I.
|
Vol 8, No 4 (2011) |
Letnyaya shkola po arterial'noy gipertonii 2011 g. v Barselone (Ispaniya) |
|
Dolgusheva Y.A., Kobal' E.A.
|
Vol 11, No 4 (2014) |
Local rigidity of the walls of the carotid artery at the site of formation of atherosclerotic plaques in patients with arterial hypertension |
(Rus)
|
Vakhovskaya T.V., Tripoten M.I., Pogorelova O.A., Balakhonova T.V., Loukianov M.M., Boytsov S.A.
|
Vol 12, No 4 (2015) |
Longitudinal deformation of the left ventricle and the left atrium in workers of railway transport with arterial hypertension |
(Rus)
|
Marsalskaya O.A., Nikiforov V.S.
|
Vol 16, No 4 (2019) |
Long-term outcomes after percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension |
(Rus)
|
Karabasheva M.B., Danilov N.M., Sagaidak O.V., Matchin Y.G., Chazova I.E.
|
Vol 13, No 1 (2016) |
Loop diuretics in the treatment of hypertension and edema syndrome |
(Rus)
|
Kirichenko A.A.
|
Vol 7, No 3 (2010) |
Lozartan v praktike terapevta |
|
Stryuk R.I.
|
Vol 13, No 3 (2016) |
Main questions of β-blockers application in clinical practice: do they all the same? |
(Rus)
|
Nebieridze D.V.
|
Vol 18, No 3 (2021) |
Management of patients with arterial hypertension and atrial fibrillation |
(Rus)
|
Chazova I.E., Golitsyn S.P., Zhernakova J.V., Zheleznova E.A., Kropacheva E.S., Mironov N.I., Kostiukevich M.V., Laiovich L.I., Utsumueva M.D., Iuricheva I.A., Litvin A.Y., Elfimova E.M., Rogoza A.N., Panchenko E.P.
|
Vol 14, No 3 (2017) |
Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level |
(Rus)
|
Avalyan A.A., Kirillova M.Y., Shitov V.N., Oshchepkova Y.V., Saidova M.A., Stenina M.B., Chazova I.Y.
|
Vol 14, No 4 (2017) |
Markers of early target-organ brain damage in essential arterial hypertension: the search continues. Possibilities of diffusion tensor magnetic resonance imaging |
(Rus)
|
Parfenov V.A., Ostroumova T.M., Ostroumova O.D., Perepelova E.M., Perepelov V.A.
|
Vol 14, No 4 (2017) |
Markers of early target-organ brain damage in essential arterial hypertension: the search continues. Possibilities of diffusion tensor magnetic resonance imaging |
(Rus)
|
Anikin G.S., Storozhuk I.K., Filyazova Y.Y.
|
Vol 12, No 1 (2015) |
Medical and social risk factors for arterial hypertension in coal miners |
(Rus)
|
Indukaeva E.V., Makarov S.A., Ogarkov M.Y.
|
Vol 9, No 2 (2012) |
Mediko-sotsial'nye aspekty priverzhennosti lecheniyu arterial'noy gipertenzii u rabotnikov promyshlennykh predpriyatiy |
|
Indukaeva E.V., Makarov S.A., Ogarkov M.Y., Artamonova G.V.
|
Vol 6, No 3 (2009) |
Mesto agonistov imidazolinovykh retseptorov v lechenii arterial'noy gipertenzii: rezul'taty issledovaniya MERSY v Rossii |
|
Chazova I.E., Mychka V.B., Ratova L.G.
|
Vol 5, No 4 (2008) |
Mesto nizkodozovykh fiksirovannykh kombinatsiy antigipertenzivnykh preparatov u patsientov s arterial'noy gipertoniey |
|
Ratova L.G., Chazova I.E.
|
Vol 8, No 2 (2011) |
Mesto sartanov v lecheniiarterial'noy gipertenzii.Aktsent na olmesartan |
|
Morozova T.E., Gurova A.Y.
|
Vol 6, No 1 (2009) |
Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients withtype 2 diabetes mellitus and mild hypertension:a sequential, randomized, double-blind clinical trial |
|
Giuseppe Derosa -., Arrigo FG Cicero -., Angela D'Angelo -., Elena Fogari -., Sibilla Salvadeo -., Alessia Gravina -., Ilaria Ferrari -., Raffaella Fassi -., Roberto Fogari -.
|
Vol 6, No 1 (2009) |
Metabolic syndrome |
|
Mychka V.B., Chazova I.E., Mychka V.B., Chazova I.E.
|
Vol 5, No 4 (2008) |
Metabolicheskie i antioksidantnye effekty nebivolola pri lechenii bol'nykh arterial'noy gipertenziey |
|
Napalkov D.A., Golovenko E.N.
|
Vol 9, No 2 (2012) |
Metabolicheskie i organoprotektivnye effekty kombinatsii amlodipina i atorvastatina u bol'nykh s metabolicheskim sindromom |
|
Blinova N.V., Saidova M.A., Tishina E.V., Chazova I.E.
|
Vol 5, No 2 (2008) |
Metabolicheskiy sindrom - mif ili real'nost'? |
|
Mychka V.B., Chazova I.E.
|
Vol 11, No 4 (2014) |
Methods of sympathetic activity evaluation in patients with systemic refractory hypertension |
(Rus)
|
Grigin V.A., Danilov N.M., Sagaydak O.V., Shelkova G.V., Chazova I.Y.
|
Vol 13, No 1 (2016) |
MicroRNA in the diagnosis of chronic heart failure: state of the problem and the results of a pilot study |
(Rus)
|
Zhirov I.V., Kochetov A.G., Zaseeva A.V., Liang O.V., Skvortsov A.A., Abramov A.A., Gimadiev R.R., Masenko V.P., Tereshchenko S.N.
|
Vol 14, No 1 (2017) |
Mitral insufficiency: systematization, conservative and surgical treatment |
(Rus)
|
Cherepanova E.V., Gurevich M.A.
|
Vol 10, No 2 (2013) |
Mnenie ekspertov Rossiyskogo meditsinskogo obshchestva po arterial'noy gipertonii: znachenie fiksirovannykh kombinatsiy v uluchshenii kontrolya arterial'nogo davleniya |
|
- -.
|
Vol 7, No 1 (2010) |
Mnogolikie sartany |
|
Polos'yants O.B., Silina E.G.
|
Vol 9, No 2 (2012) |
Mochevaya kislota i funktsiya endoteliya mikrotsirkulyatornogo rusla u bol'nykh na rannikh stadiyakh arterial'noy gipertonii |
|
Atyunina I.V., Oshchepkova E.V., Fedorovich A.A., Dmitriev V.A., Gushchina O.V., Titov V.N., Rogoza A.N.
|
Vol 8, No 3 (2011) |
Mochevaya kislotai serdechno-sosudistye zabolevaniya:novyy S-reaktivnyy belok? |
|
Gilyarevskiy S.R., Kuz'mina I.M., Kelekhsaev K.R.
|
Vol 10, No 4 (2013) |
Modern approaches to combined therapy of arterial hypertension |
|
Napalkov D.A., Zhilenko A.V.
|
Vol 15, No 4 (2018) |
Modern combination antihypertensive pharmacotherapy |
(Rus)
|
Mubarakshina O.A., Somova M.N., Batishcheva G.A.
|
Vol 14, No 4 (2017) |
Modern concepts of the relationship between obesity and erectile dysfunction in patients with arterial hypertension |
(Rus)
|
Alekseeva T.A., Litvin A.Y.
|
Vol 11, No 3 (2014) |
Modern opportunities of monotherapy in patients with arterial hypertension associated with comorbid disorders |
(Rus)
|
Gorokhovskaya G.N., Yun V.L.
|
Vol 10, No 4 (2013) |
Modern possibilities of hypertension drug therapy. Candesartan and its place in the therapy |
|
Barbarash O.L., Kashtalap V.V.
|
Vol 11, No 4 (2014) |
Modernization of hypertension treatment in the Yaroslavl region: interim results of the yearly comprehensive program for modernization of the regional healthcare system |
(Rus)
|
Mozheyko M.E., Eregin S.Y., Vigdorchik A.V., Klimovskaia I.M., Riahi F., Hughes D.
|
Vol 12, No 4 (2015) |
Myocardial ischemia in patients with pulmonary arterial hypertension |
(Rus)
|
Arkhipova O.A., Martyniuk T.V., Valeeva E.G., Ryabykina G.V., Samoylenko L.E., Sergienko V.B., Chazova I.E.
|
Vol 11, No 2 (2014) |
National questionnaire of treatment compliance:testing and application in outpatient practice |
(Rus)
|
Fofanova T.V., Ageev F.T., Smirnova M.D., Svirida O.N., Kuzmina A.E., Thostov A.S., Nelyubina A.S.
|
Vol 11, No 3 (2014) |
Nebivolol for treatment patients with arterial hypertension |
(Rus)
|
Mikheeva O.M., Komisarenko I.A.
|
Vol 1, No 2 (2004) |
Nefroprotektivnyy effekt antigipertenzivnoy terapii: issledovanie IRIS |
|
Ratova L.G., Chazova I.E.
|
Vol 8, No 1 (2011) |
Nefroprotektivnyy effekt fiksirovannoy kombinatsii lizinoprila i amlodipina u bol'nykh sakharnym diabetom i arterial'noygipertenziey. |
|
Protasov K.V., Fedorishina O.V., Dzizinskiy A.A., Antonenko N.B., Boronova V.B., Mamonova T.A., Tsareva L.A., Panteleeva E.O.
|
Vol 2, No 1 (2005) |
Nefroprotektsiya v lechenii bol'nykh arterial'noy gipertoniey (rezul'taty issledovaniya IRIS) |
|
Chazova I.E., Ratova L.G., Kolos I.P., Kotkina T.I., Martsevich S.Y., Moiseeva O.M., Kozyreva M.P., Dmitrieva N.A., Semenova Y.A., Andreeva G.F., Voronina V.P., Lukina Y.V., Ivanenkova P.Y., Serazhim A.A., Fel'dsherova N.A.
|
Vol 9, No 3 (2012) |
Nemedikamentoznye metody lecheniya patsientov s arterial'noy gipertenziey i bronkhoobstruktivnoy patologiey |
|
Zykov K.A., Ratova L.G., Agapova O.Y., Chazova I.E.
|
Vol 13, No 2 (2016) |
Nephroprotective in patients with metabolic syndrome: approaches to the appointment of antihypertensive drugs |
(Rus)
|
Ostroumova O.D., Zykova A.A., Maksimov M.L.
|
Vol 16, No 4 (2019) |
New approaches to the analysis of daily variability of sinus rhythm in assessing the antihypertensive effect of various drugs |
(Rus)
|
Sobolev A.V., Talabanov P.G., Ryabykina G.V., Kozhemyakina E.S., Oshchepkova E.V.
|
Vol 17, No 2 (2020) |
New opportunities for reducing cardiovascular risk in the Russian Federation |
(Rus)
|
Ostroumova O.D., Sergienko I.V., Zhernakova Y.V.
|
Vol 11, No 1 (2014) |
New trends in the treatment of hypertension in 2013: the renaissance of pulse pressure |
(Rus)
|
Ostroumova O.D., Galeeva N.Y.
|
Vol 15, No 2 (2018) |
Nitrogen oxide biochemical pathway in pulmonary arterial hypertension therapy and REPLACE trial results |
(Rus)
|
Shmalts A.A., Gorbachevsky S.V.
|
Vol 10, No 3 (2013) |
Novoe pokolenie blokatorov retseptorov angiotenzina |
|
Podzolkov V.I., Tarzimanova A.I.
|
Vol 5, No 2 (2008) |
Novye Evropeyskie rekomendatsii po vedeniyu patsientov s arterial'noy gipertoniey: mesto sartanov |
|
Chazova I.E.
|
Vol 8, No 3 (2011) |
Novye Rossiyskie rekomendatsiipo AG - prioritet kombinirovannoyterapii |
|
Arkhipov M.V., Arutyunov G.P., Boytsov S.A., Galyavich A.S., Karpov Y.A., Kobalava Z.D., Makolkin V.I., Martynov A.I., Nebieridze D.V., Nedogoda S.V., Ostroumova O.D., Oshchepkova E.V., Smolenskaya O.G., Shal'nova S.A., Chazova I.E.
|
Vol 3, No 2 (2006) |
Novye vozmozhnosti v lechenii bol'nykh s metabolicheskim sindromom (rezul'taty issledovaniya ALMAZ) |
|
Chazova I.E., Mychka V.B.
|
Vol 5, No 3 (2008) |
Novye vozmozhnosti v lechenii serdechno-sosudistykh zabolevaniy: rezul'taty issledovaniya ONTARGET |
|
Chazova I.E.
|
Vol 5, No 4 (2008) |
Novye vozmozhnosti v strategii lecheniya bol'nykh s idiopaticheskoylegochnoy gipertenziey: antagonist retseptorov endotelina bozentan |
|
Martynyuk T.V., Chazova I.E.
|
Vol 7, No 4 (2010) |
Novyy b1-adrenoblokator s vazodilatiruyushchim effektom Binelol®: antigipertenzivnye, mikrotsirkulyatornye i metabolicheskie effekty. |
|
Spasskaya M.B., Kulieva G.R., Safaryan A.S., Ivanishina N.S.
|
Vol 3, No 1 (2006) |
Novyy predstavitel' klassa statinov - krestor: vozmozhnosti v lechenii bol'nykh s metabolicheskim sindromom |
|
Chazova I.E., Mychka V.B., Mamyrbaeva K.M., Masenko V.P., Flegontova N.V., Sergienko V.B.
|
Vol 16, No 1 (2019) |
Obesity and hypertension: the role of criteria |
(Rus)
|
Tsygankova D.P., Krivoshapova K.E., Maksimov S.A., Indukaeva E.V., Shapovalova E.B., Artamonova G.V., Barbarash O.L.
|
Vol 15, No 3 (2018) |
Obesity as a predictor for cardiovascular disease development: role of localized fat depot |
(Rus)
|
Azimova M.O., Blinova N.V., Zhernakova Y.V., Chazova I.E.
|
Vol 17, No 4 (2020) |
Obesity as a risk factor of contrast-induced acute kidney injury in patients with arterial hypertension and stable coronary artery disease |
(Rus)
|
Mironova O.I., Sivakova O.A., Fomin V.V.
|
Vol 8, No 1 (2011) |
Obrashchenie k doktoru |
|
- -.
|
Vol 4, No 2 (2007) |
Obratimyy stenoz i fibromyshechnaya displaziya pochechnoy arterii v sluchae feokhromotsitomy |
|
Potapova G.N., Kazanchyan P.A., Veselova S.P., Samko A.N., Masenko V.P., Sitina V.K., Chazova I.E.
|
Vol 4, No 2 (2007) |
Obrazovatel'nyy Master-kurs po arterial'noy gipertonii i serdechno-sosudistomu risku |
|
- -.
|
Vol 6, No 2 (2009) |
Obstructive sleep apnea syndrome |
|
Litvin A.Y., Chazova I.E.
|
Vol 6, No 1 (2009) |
Obstructive sleep apnea syndrome |
|
Litvin A.Y., Chazova I.E., Litvin A.Y., Chazova I.E.
|
Vol 9, No 1 (2012) |
Obzor meropriyatiya. VIII Vserossiyskiy kongress «Arterial'naya gipertoniya: ot A.L.Myasnikova do nashikh dney» |
|
- -.
|
Vol 9, No 4 (2012) |
On the occasion of the birthday of Sergey N.Nakonechnikov |
|
- -.
|
Vol 11, No 4 (2014) |
Once again about the clinical efficacy and safety of sartans |
(Rus)
|
Minina Y.S., Khadzhieva B.R.
|
Vol 3, No 2 (2006) |
Opredeleno li mesto beta-adrenoblokatorov pri lechenii arterial'noy gipertonii? |
|
Makolkin V.I.
|
Vol 11, No 1 (2014) |
Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors |
(Rus)
|
Trukhan D.I., Tarasova L.V.
|
Vol 7, No 2 (2010) |
Optimizatsiya antigipertenzivnoy terapii u bol'nykh arterial'noy gipertoniey vysokogo riska: novaya rossiyskaya programma STRATEGIYa A.(roSsiyskaya mnogotsenTrovaya pRogrammA po otsenke effekTivnosti noliprEla A forte u patsientov s arterial'noy GIpertoniey vysokogo riska s nedostatochnym kontrolem arterial'nogo davleniYa) |
|
Chazova I.E., Martynyuk T.V.
|
Vol 8, No 3 (2011) |
Optimizatsiya antigipertenzivnoyterapii u patsientov s khronicheskoyserdechnoy nedostatochnost'yuI-II funktsional'nykh klassov |
|
Kanorskiy S.G., Tregubov V.G., Pokrovskiy V.M.
|
Vol 9, No 1 (2012) |
Optimizatsiya lecheniya ishemicheskoy bolezni serdtsa i arterial'noy gipertonii pri primenenii zofenoprila |
|
Evdokimova A.G., Evdokimov V.V., Smetanin A.V., Leonenko N.V., Churkina N.V.
|
Vol 2, No 2 (2005) |
Optimizatsiya lecheniya patsientov s sochetannymi formami arterial'noy gipertonii i ishemicheskoy bolezni serdtsa |
|
Volkova E.G.
|
Vol 15, No 4 (2018) |
Organoprotection with arterial hypertension 2-3 degrees |
(Rus)
|
Afonicheva I.I., Melnik M.V., Knyazeva S.A., Kazyulin A.A.
|
301 - 400 of 734 Items |
<< < 1 2 3 4 5 6 7 8 > >> |